These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 23598398)

  • 1. Understanding immunosenescence to improve responses to vaccines.
    Goronzy JJ; Weyand CM
    Nat Immunol; 2013 May; 14(5):428-36. PubMed ID: 23598398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related decline in immunity: implications for vaccine responsiveness.
    Kumar R; Burns EA
    Expert Rev Vaccines; 2008 May; 7(4):467-79. PubMed ID: 18444893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination in the elderly: an immunological perspective.
    Chen WH; Kozlovsky BF; Effros RB; Grubeck-Loebenstein B; Edelman R; Sztein MB
    Trends Immunol; 2009 Jul; 30(7):351-9. PubMed ID: 19540808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The twilight of immunity: emerging concepts in aging of the immune system.
    Nikolich-Žugich J
    Nat Immunol; 2018 Jan; 19(1):10-19. PubMed ID: 29242543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.
    Pereira B; Xu XN; Akbar AN
    Front Immunol; 2020; 11():583019. PubMed ID: 33178213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Senescence, Immunosenescence and HIV.
    Fülöp T; Herbein G; Cossarizza A; Witkowski JM; Frost E; Dupuis G; Pawelec G; Larbi A
    Interdiscip Top Gerontol Geriatr; 2017; 42():28-46. PubMed ID: 27875822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age-related decline in vaccination efficacy: The potential role of myeloid derived suppressor cells.].
    Perfilyeva YV; Karalnik BV; Ostapchuk YO; Kali A; Tleulieva RT; Abdolla N; Krasnoshtanov VK; Belyaev NN
    Adv Gerontol; 2020; 33(4):785-795. PubMed ID: 33342113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global challenge and future strategies for keeping the world's aging population healthy by vaccination.
    Steeper M; Plebanski M; Flanagan KL
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):427-31. PubMed ID: 27618919
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
    Fujihashi K; Kiyono H
    Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging and influenza vaccine-induced immunity.
    Dugan HL; Henry C; Wilson PC
    Cell Immunol; 2020 Feb; 348():103998. PubMed ID: 31733824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosenescence and vaccine failure in the elderly: strategies for improving response.
    Boraschi D; Italiani P
    Immunol Lett; 2014 Nov; 162(1 Pt B):346-53. PubMed ID: 24960535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity.
    Oh SJ; Lee JK; Shin OS
    Immune Netw; 2019 Dec; 19(6):e37. PubMed ID: 31921467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systems biology approach to the effect of aging, immunosenescence and vaccine response.
    Poland GA; Ovsyannikova IG; Kennedy RB; Lambert ND; Kirkland JL
    Curr Opin Immunol; 2014 Aug; 29():62-8. PubMed ID: 24820347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of immune responses to vaccines in elderly persons.
    Weinberger B; Herndler-Brandstetter D; Schwanninger A; Weiskopf D; Grubeck-Loebenstein B
    Clin Infect Dis; 2008 Apr; 46(7):1078-84. PubMed ID: 18444828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence in lymphoid organs and immunosenescence.
    Budamagunta V; Foster TC; Zhou D
    Aging (Albany NY); 2021 Aug; 13(15):19920-19941. PubMed ID: 34382946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
    Lang PO; Aspinall R
    Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.
    Aiello A; Ligotti ME; Garnica M; Accardi G; Calabrò A; Pojero F; Arasanz H; Bocanegra A; Blanco E; Chocarro L; Echaide M; Fernandez-Rubio L; Ramos P; Piñeiro-Hermida S; Kochan G; Zareian N; Farzaneh F; Escors D; Caruso C; Candore G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding immunosenescence and its impact on vaccination of older adults.
    Allen JC; Toapanta FR; Chen W; Tennant SM
    Vaccine; 2020 Dec; 38(52):8264-8272. PubMed ID: 33229108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosenescence and vaccination of the elderly, I. Age-related immune impairment.
    Ongrádi J; Stercz B; Kövesdi V; Vértes L
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):199-210. PubMed ID: 19789136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.
    Garnica M; Aiello A; Ligotti ME; Accardi G; Arasanz H; Bocanegra A; Blanco E; Calabrò A; Chocarro L; Echaide M; Kochan G; Fernandez-Rubio L; Ramos P; Pojero F; Zareian N; Piñeiro-Hermida S; Farzaneh F; Candore G; Caruso C; Escors D
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.